Zilucoplan for treating antibody positive generalised myasthenia gravis [ID4008]

Appeal

Appeal letter : Appeal letter (MSWord 186 KB)

Scrutiny letter : Scrutiny letter (MSWord 97 KB)

Response to scrutiny letter : Response to scrutiny letter (MSWord 27 KB)

Final scrutiny letter : Final scrutiny letter (MSWord 81 KB)

Appeal letter : Appeal letter (MSWord 85 KB)

Scrutiny letter : Scrutiny letter (MSWord 100 KB)

Response to scrutiny letter : Response to scrutiny letter (MSWord 77 KB)

Final scrutiny letter : Final scrutiny letter (MSWord 82 KB)

Appeal letter : Appeal letter (MSWord 142 KB)

Scrutiny letter : Scrutiny letter (MSWord 97 KB)

Response to scrutiny letter : Response to scrutiny letter (MSWord 106 KB)

Final scrutiny letter : Final scrutiny letter (MSWord 81 KB)

Appeal letter : Appeal letter (MSWord 134 KB)

Scrutiny letter : Scrutiny letter (MSWord 93 KB)

Response to scrutiny letter : Response to scrutiny letter (MSWord 165 KB)

Final draft guidance

Final draft guidance (PDF 320 KB)

Equality impact assessment (downloadable version) (PDF 126 KB)

Committee papers (PDF 1.83 MB)

Draft guidance: 2

Draft consultation document (online commenting)

Draft guidance (downloadable version) (PDF 337 KB)

Equality and health inequalities assessment (downloadable version) (PDF 123 KB)

Public committee slides (PDF 787 KB)

Draft guidance: 1

Draft guidance (downloadable version) (PDF 229 KB)

Draft consultation document (online commenting)

Equality impact assessment (downloadable version) (PDF 123 KB)

Committee papers (PDF 4.9 MB)

Final scope (PDF 196 KB)

Final stakeholder list (PDF 166 KB)

Equality impact assessment (Scoping) (PDF 126 KB)

Draft matrix post referral (PDF 166 KB)